ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 764,61
0,06%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PolyPid Ltd (PYPD)

  7. PolyPid Ltd (PYPD) Actualités

PYPD

PolyPid (PYPD)

PolyPid Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PYPD
DateHeureSourceTitreSymboleSociété
28/05/202422h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
06/03/202422h28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PYPDPolyPid Ltd
06/03/202422h05Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PYPDPolyPid Ltd
01/03/202418h19Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYPDPolyPid Ltd
14/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PYPDPolyPid Ltd
01/02/202423h26Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PYPDPolyPid Ltd
22/01/202414h00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PYPDPolyPid Ltd
18/10/202323h07AllPennyStocks.comNew Collaboration Could Revolutionize Treatment of Chronic Spinal Cord InjuriesNASDAQ:PYPDPolyPid Ltd
22/06/202313h12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PYPDPolyPid Ltd
22/05/202315h54Dow Jones NewsFDA Approves PolyPid's Trial Design for D-PLEXNASDAQ:PYPDPolyPid Ltd
17/05/202317h09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PYPDPolyPid Ltd
31/03/202321h55Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PYPDPolyPid Ltd
31/03/202312h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PYPDPolyPid Ltd
24/01/202316h24Dow Jones NewsPolyPid Shares Rise 28% After Positive FDA News for D-PLEXNASDAQ:PYPDPolyPid Ltd
12/12/202215h50TipRanksAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
09/11/202220h45TipRanksPolyPid (PYPD) Gets a Buy from JMP SecuritiesNASDAQ:PYPDPolyPid Ltd
28/09/202219h35TipRanksJMP Securities Sticks to Its Buy Rating for PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
02/09/202218h15TipRanksJMP Securities Remains a Buy on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
11/08/202217h06TipRanksAnalysts’ Top Healthcare Picks: PolyPid (PYPD), Nuvalent (NUVL)NASDAQ:PYPDPolyPid Ltd
10/08/202217h15TipRanksJMP Securities Keeps Their Buy Rating on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
24/06/202215h29TipRanksBMO Capital Thinks PolyPid’s Stock is Going to RecoverNASDAQ:PYPDPolyPid Ltd
23/06/202220h25TipRanksJMP Securities Thinks PolyPid’s Stock is Going to RecoverNASDAQ:PYPDPolyPid Ltd
23/05/202217h25TipRanksAnalysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Nektar Therapeutics (NKTR)NASDAQ:PYPDPolyPid Ltd
12/05/202214h51TipRanksBMO Capital Keeps a Buy Rating on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
11/05/202218h49TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Agenus (AGEN), Intercept Pharma (ICPT) and PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
24/02/202219h18Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PYPDPolyPid Ltd
04/01/202207h53TipRanksPolypid Names New CEO; Shares Jump 6.3%NASDAQ:PYPDPolyPid Ltd
16/12/202106h25TipRanksPolyPid (PYPD) Gets a Buy Rating from JMP SecuritiesNASDAQ:PYPDPolyPid Ltd
30/08/202122h17Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:PYPDPolyPid Ltd
12/07/202112h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PYPDPolyPid Ltd
 Showing the most relevant articles for your search:NASDAQ:PYPD

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
EU
AF
Air FranceKLM
EU
VIV
Vivendi
NYSE
NKE
Nike
EU
AI
Air Liquide
NYSE
KO
Coca Cola
EU
CS
Axa
EU
PX1
CAC 40
NYSE
JPM
JP Morgan Chase
EU
GLE
Societe Generale
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés